| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
3 companies
Ceesay Abraham is a Chief Executive Officer at Rapport Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 10,916 | $29.64 | $323,508.33 | -0.6% | -3.3% | - | |
| Nov 17, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 10,916 | $25.20 | $275,046.92 | -0.9% | +15.7% | - | |
| Oct 15, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 10,916 | $25.81 | $281,729.14 | -0.9% | +5.1% | - | |
| Sep 17, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sell | 76,420 | $26.32 | $2,011,197.18 | -5.7% | +17.0% | - | |
| Sep 4, 2025 | PCRX Pacira Biosciences, Inc. | Director | Sell | 2,354 | $27.19 | $64,005.26 | -20.7% | -9.5% | - |